Milestone Scientific Inc (MLSS)
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$0.47+0.06%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · MLSS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 9.4 | 9.0 | 8.6 | 9.8 | 8.8 | 10.3 | 5.4 | 8.4 | 9.6 | 11.3 | 10.5 | 9.5 | 10.3 | 10.0 | 8.6 | 8.4 |
| Cost of Revenues | 2.8 | 2.6 | 2.2 | 3.0 | 3.9 | 4.0 | 1.8 | 2.7 | 5.2 | — | — | — | — | — | — | — |
| Gross Profit | 6.6 | 6.4 | 6.4 | 6.8 | 4.9 | 6.3 | 3.6 | 5.7 | 4.4 | 7.0 | 6.3 | 6.4 | 6.7 | 6.8 | 5.6 | 5.4 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 10.6 | 11.6 | 12.3 | 13.1 | 12.5 | 12.7 | 10.7 | 9.5 | 10.6 | 11.9 | 11.5 | 9.4 | 7.4 | 5.5 | 5.9 | 6.4 |
| R&D Expenses | — | 0.4 | 0.9 | 0.7 | 1.2 | 0.9 | 0.3 | 0.2 | 0.2 | 0.3 | 1.3 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 |
| Operating Income | (4.1) | (5.7) | (6.8) | (7.1) | (8.8) | (7.4) | (7.5) | (4.0) | (8.0) | (5.2) | (6.5) | (3.1) | (0.8) | 1.1 | (0.5) | (1.2) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.1 | 0.2 | 0.1 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.1 | 0.2 | 0.1 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | — | (0.0) | 0.0 | — | — | — |
| EBT, Incl. Unusual Items | (4.1) | (5.7) | (4.7) | (7.0) | (8.8) | (7.1) | (7.5) | (7.6) | (8.0) | (5.2) | (6.5) | (3.1) | (1.7) | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (0.0) | 0.0 | 0.0 | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | — | (0.1) | (0.1) | (0.1) | (0.1) | (0.1) | (0.3) | (0.2) | (1.3) | (0.1) | (0.0) | — | — | — |
| Net Income | 7.3 | (5.7) | (4.7) | 6.9 | (8.7) | (6.8) | (7.3) | (7.5) | (7.4) | (5.2) | (5.9) | (5.5) | (1.7) | 1.5 | (0.9) | (1.5) |
| Per Share | ||||||||||||||||
| Basic EPS | 0.08 | (0.07) | (0.06) | (0.10) | (0.12) | (0.10) | (0.12) | (0.16) | (0.21) | (0.16) | (0.22) | (0.26) | (0.08) | 0.09 | — | — |
| Diluted EPS | 0.08 | (0.07) | — | — | — | (0.10) | (0.12) | (0.16) | (0.21) | (0.16) | (0.22) | (0.26) | (0.08) | 0.08 | — | — |
| Revenue per Share | 0.10 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 93.1 | 82.1 | 79.8 | 72.8 | 70.6 | 68.8 | 63.1 | 45.7 | 35.3 | 32.7 | 27.0 | 21.4 | 20.1 | 17.1 | — | — |
| Diluted Weighted Avg Shares | 93.1 | 82.1 | — | — | — | 68.8 | 63.1 | 45.7 | 35.3 | 32.7 | 27.0 | 21.4 | 20.1 | 17.5 | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (5.6) | (6.7) | (7.0) | (8.8) | (7.3) | (7.4) | (3.9) | (7.1) | — | — | — | — | — | — | — |
| EBIT | (4.1) | (5.7) | (6.8) | (7.1) | (8.8) | (7.4) | (7.5) | (4.0) | (8.0) | (5.2) | (6.5) | (3.1) | (0.8) | 1.1 | (0.5) | (1.2) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | -0.0% | -0.2% | -0.2% | -0.3% | -0.4% | 0.3% | -1.2% | -0.6% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.